Risk factors for atrial fibrillation recurrence post Cox-maze IV performed without pre-exclusion.
New Society of Thoracic Surgeons guidelines recommend adding surgical ablation as a concomitant procedure for Class I indications. We performed the maze procedure for all cases that experienced atrial fibrillation (AF) prior to cardiac surgery, without surgeon pre-exclusion. We retrospectively analyzed 83 patients, aged 71 ± 11 (22% >80) years, who underwent Cox-maze IV for persistent AF between 2014 and 2017. The mean AF duration (AFD) was 6.9 ± 8.6 years and EuroSCORE II was 7.2 ± 6.8. The 30-day mortality was 2.4%. During follow-up (mean, 675 days), the 1, 2, and 3 y survival rates were 92%, 86%, and 82%, respectively. No strokes were observed despite a mean CHA2DS2-VASC score of 4.1 (expected stroke rate, 4%/y). Twelve patients required a new pacemaker; 56/73 survivors (77%) remained AF-free. Multivariate logistic regression identified preoperative AFD, f wave size, and mean heart rate per Holter as significant risk factors for AF recurrence, with AFD as the most significant: 98% of patients with AFD <5 y remained AF-free. Although the AF-free rate with the AFD ≥5 was only 55%, their symptoms improved without heart failure readmission. Concomitant atrial plication was performed more frequently in the AFD ≥5, with greater atrial volume reduction and significant increases in stroke volume. The Cox maze IV procedure performed without pre-exclusions showed reasonable survival rates. Although AF recurred in patients with longer AFD, they fared well with significant increases in stroke volume. Concomitant atrial volume reduction may have contributed to these additional benefits.